Journal article

Three decades of hepatitis B control with vaccination

Hepatitis B virus (HBV) continues to represent a major health problem and can lead to acute liver failure, acute hepatitis, chronic carriership, chronic hepatitis of HBV, liver cirrhosis, liver cancer, liver transplantation and death. There is a marked difference in the geographic distribution of carriers. More than 240 million people worldwide are chronic HBV carriers. Mother-to-child transmission remains the most important mechanism of infection in countries with a high prevalence of HBV. Percutaneous/parenteral transmission and unsafe sexual practices are important mode of spread transmission of HBV in other countries. Vaccination against HBV is the gold measure for primary prevention and control of the disease. Currently, 179 countries have added HBV vaccination to their routine vaccination programs with great results. Neonatal immunization with HBV vaccine has been one of the most highly effective measures in public health and the first anti-cancer program to be launched. In this paper we review the achievements for the last three decades.

Languages

  • English

Publication year

2015

Journal

World J Hepatol

Volume

18

Type

Journal article

Categories

  • Service delivery

Diseases

  • Hepatitis B

Countries

  • China
  • Gambia
  • Spain

Tags

  • Coverage monitoring
  • Performance monitoring

WHO Regions

  • African Region
  • European Region
  • Western Pacific Region